Walleye Trading
ACUR

Walleye Trading’s Acura Pharmaceuticals ACUR Stock Holding History

Walleye Trading’s Portfolio ACUR Stock Details ACUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10
Closed – – 5485
2016
Q4 		$0 Hold
10
– – ﹤0.01% 5547
2016
Q3 		$0 Hold
10
– – ﹤0.01% 5867
2016
Q2 		$0 Sell
10
-1,103
-99% -$2.85K ﹤0.01% 6036
2016
Q1 		$3K Sell
1,113
-1,619
-59% -$3.44K ﹤0.01% 5092
2015
Q4 		$7K Buy
2,732
+1,532
+128% +$3.72K ﹤0.01% 4852
2015
Q3 		$3K Buy
+1,200
New +$4.08K ﹤0.01% 4744

Other funds holding ACUR

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Walleye Trading's ACUR Position: Q1 2017 in Review

Walleye Trading sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 10 shares.

Walleye Trading first reported a position in ACUR in Q3 2015 and held it in 6 quarters. The position peaked at $7K in Q4 2015. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

  • Walleye Trading reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Walleye Trading sold 10 Acura Pharmaceuticals shares in Q1 2017.
  • Walleye Trading first reported a position in Acura Pharmaceuticals in Q3 2015 and held it in 6 quarters.
  • Walleye Trading's Acura Pharmaceuticals position peaked at $7K in Q4 2015.
  • 3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Walleye Trading's 13F filing for Q1 2017, filed 15 May 2017.